Abstract
Prolactin (PRL) in human serum is present in three species: monomeric PRL (23 kDA), big PRL (50–60 kDa) and big, big PRL (bb-PRL or macroprolactinemia) of 150–170 kDa. Macro-prolactin seems to be mainly composed of a molecule of monomeric PRL and an immunoglobulin G anti PRL. Its biological activity is considered low or absent, but it is measured, at various degrees, by the immunoassay method, thus causing diagnostic problems. Polyethylene Glycol (PEG) has been employed to precipitate macroprolactin, allowing its detection. This method is not applicable to all immunoassays for technical reasons. Our aim was to evaluate: 1) the predictability of macroprolactin on a clinical basis; 2) the possibility of applying PEG precipitation to Abbott AxSYM® analyzer beside Roche Elecsys® (already approved). We classified 34 hyperprolactinemic women, on a clinical and imaging basis, in four groups: A: functional hyperprolactinemia; B: pituitary lesions hyperprolactinemia; C: probably macroprolactinemia; D: unclassifiable hyperprolactinemia and a “control” group E of 19 healthy women. PRL was assayed, both with Elecsys® and AxSYM®, before and after PEG serum treatment. Eleven out of twelve group C, and 5/7 group D patients showed macroprolactinemia, against 1/7 in A and 1/8 in B. PEG was suitable for AxSYM® only after the same treatment of the calibration standards, thus performing outcomes overlapping Elecsys®. For clinical purposes, in the presence of macroprolactinemia, besides the recovery ratio, molar or ponderal monomeric PRL assay should be calculated.
Similar content being viewed by others
References
Smith C.R., Norman M.R. Prolactin and growth hormone: molecular heterogeneity and measurement in serum. Ann. Clin. Biochem. 1990, 27: 542–550.
Lindstedt G. Endogenous antibodies against prolactin— a “new” cause of hyperprolactinemia. Eur. J. Endocrinol. 1994, 130: 429–432.
Cavaco B., Leite V., Santos M.A., Arranhado E., Sobrinho L.G. Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma. J. Clin. Endocrinol. Metab. 1995, 80: 2342–2346.
Leite V., Cosby H., Sobrinho L.G., Fresnoza A., Amparo Santos M., Friesen H.G Characterization of big, big proactin in patients with hyperprolactinaemia. Clin. Endocrinol. (Oxf). 1992, 37: 365–372.
Hattori N. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies. J. Clin. Endocrinol. Metab. 1996, 81: 586–590.
Pascoe-Lira D., Duran-Reyes G., Contreras-Hernandez I., Manuel-Apolinar L., Blanco-Favela F., Leanos-Miranda A. Frequency of macroprolactinemia due to autoantibodies against prolactin in pregnant women. J. Clin. Endocrinol. Metab. 2001, 86: 924–929.
Hattori N., Ikekubo K., Ishihara T., Moridera K., Hino M., Kurahachi H. Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody. Eur. J. Endocrinol. 1994, 130: 438–45.
Corenblum B. Asymptomatic hyperprolactinemia resulting from macroprolactinemia. Fertil. Steril. 1990, 53: 165–167.
Fideleff H.L., Ruibal G., Boquete H., Pujol A., Sequera A., Sobrado P. Macroprolactinemia in childhood and adolescence: a cause of asymptomatic hyperprolactinemia. Horm. Res. 2000, 53: 16–19.
Blanco-Favela F., Chavez-Rueda K.A., Leanos-Miranda A. Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus. Lupus 2001, 10: 757–761.
Leanos-Miranda A., Chavez-Rueda K.A., Blanco-Favela F. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus. Arthritis. Rheum. 2001, 44: 866–875.
Andersen A.N., Pedersen H., Djursing H., Andersen B.N., Friesen H.G. Bioactivity of prolactin in a woman with an excess of large molecular size prolactin, persistent hyperprolactinemia and spontaneous conception. Fertil. Steril. 1982, 38: 625–6288 (VRF).
Vieira J.G., Tachibana T. T., Obara L. H. Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia. Clin. Chem. 1998, 44: 1758–1759.
Fahie-Wilson M.N., Soule S.G. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann. Clin. Biochem. 1997, 34: 252–258.
Fahie-Wilson M., Brunsden P., Surrey J., Everitt A. Macroprolactin and the Roche Elecsys prolactin assay: characteristics of the reaction and detection by precipitation with polyethylene glycol. Clin. Chem. 2000 46: 1993–1995.
Sanchez-Eixeres M.R., Mauri M., Alfayate R. et al. Prevalence of macroprolactin detected by Elecsys 2010. Horm. Res. 2001, 56: 87–92.
Sapin R., Gasser F., Grucker D. Free prolactin determinations in hyperprolactinemic men with suspicion of macroprolactinemia. Clin. Chim. Acta 2002, 316: 33–41.
Hattori N., Ikekubo K., Ishihra T., Moridera K., Hino M., Kurahachi H. Effects of anti-prolactin autoantibodies on serum prolactin measurements. Eur. J. Endocrinol. 1994, 130: 434–437.
Malarkey W. B., Jackson R., Wortsman J. Long-term assessment of patients with macroprolactinemia. Fertil. Steril. 1988, 50: 413–418.
Olukoga A.O., Kane J.W. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin. Endocrinol. (Oxf). 1999, 51: 119–126.
Vallette-Kasic S., Morange-Ramos I., Selim A. et al. Macroprolactinemia revisited: a study on 106 patients. J. Clin. Endocrinol. Metab. 2002 87: 581–588.
Cavaco B., Prazeres S., Santos M.A. Sobrinho L.G., Leite V. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays. J. Endocrinol. Invest. 1999, 22: 203–208.
Schneider W., Marcovitz S., Al-Shammari S., Yago S., Chevalier S. Reactivity of macroprolactin in common automated immunoassays. Clin. Biochem. 2001, 34: 469–473.
Leslie H., Courtney C.H., Bell P.M. et al. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J. Clin. Endocrinol. Metab. 2001, 86: 2743–2746.
Gilson G., Schmit P., Thix J., Hoffman J.P., Humbel R.L. Prolactin results for samples containing macroprolactin are method and sample dependent. Clin. Chem. 2001, 47: 331–333.
Larrea F., Escorza A., Valero A. Heterogeneity of serum prolactin throughout the menstrual cycle and pregnancy in hyperprolactinemic women with normal function. J. Clin. Endocrinol. Metab. 1989, 68: 982–987.
Jackson R.D., Wortsman J., Malarkey W.B. Persistence of arge molecular weight prolactin secretion during pregnancy in women with macroprolactinemia and its presence in fetal cord blood. J Clin Endocrinol Metab. 1989, 68: 1046–1050.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Amadori, P., Dilberis, C., Marcolla, A. et al. Macroprolactinemia: Predictability on clinical basis and detection by PEG precipitation with two different immunometric methods. J Endocrinol Invest 26, 148–156 (2003). https://doi.org/10.1007/BF03345144
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345144